nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—systemic scleroderma—psoriasis	0.516	1	CtDrD
Lisinopril—ACE—psoriasis	0.293	1	CbGaD
Lisinopril—ABCB1—Mycophenolate mofetil—psoriasis	0.00895	0.168	CbGbCtD
Lisinopril—ABCB1—Betamethasone—psoriasis	0.00768	0.144	CbGbCtD
Lisinopril—ABCB1—Prednisolone—psoriasis	0.00758	0.142	CbGbCtD
Lisinopril—ABCB1—Hydrocortisone—psoriasis	0.00718	0.135	CbGbCtD
Lisinopril—ABCB1—Prednisone—psoriasis	0.00715	0.134	CbGbCtD
Lisinopril—ABCB1—Cyclosporine—psoriasis	0.00678	0.127	CbGbCtD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—REN—psoriasis	0.00559	0.186	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—REN—psoriasis	0.00533	0.177	CbGpPWpGaD
Lisinopril—ABCB1—Dexamethasone—psoriasis	0.00447	0.0837	CbGbCtD
Lisinopril—ABCB1—Methotrexate—psoriasis	0.00359	0.0672	CbGbCtD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—ACE—psoriasis	0.00349	0.116	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—ACE—psoriasis	0.00333	0.11	CbGpPWpGaD
Lisinopril—ACE—Metabolism of Angiotensinogen to Angiotensins—REN—psoriasis	0.0025	0.083	CbGpPWpGaD
Lisinopril—ACE—ACE Inhibitor Pathway—REN—psoriasis	0.00238	0.0791	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—REN—psoriasis	0.00147	0.0488	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—ACE—psoriasis	0.000918	0.0305	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—REN—psoriasis	0.000657	0.0218	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—LEP—psoriasis	0.00057	0.0189	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL22—psoriasis	0.000546	0.0181	CbGpPWpGaD
Lisinopril—Fosinopril—ACE—psoriasis	0.000428	0.144	CrCbGaD
Lisinopril—Spirapril—ACE—psoriasis	0.000345	0.116	CrCbGaD
Lisinopril—Moexipril—ACE—psoriasis	0.000331	0.111	CrCbGaD
Lisinopril—Quinapril—ACE—psoriasis	0.000307	0.103	CrCbGaD
Lisinopril—Cilazapril—ACE—psoriasis	0.000307	0.103	CrCbGaD
Lisinopril—Ramipril—ACE—psoriasis	0.000298	0.1	CrCbGaD
Lisinopril—Trandolapril—ACE—psoriasis	0.000298	0.1	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—REN—psoriasis	0.000278	0.00922	CbGpPWpGaD
Lisinopril—Benazepril—ACE—psoriasis	0.000267	0.0899	CrCbGaD
Lisinopril—ACE—Peptide hormone metabolism—LEP—psoriasis	0.000255	0.00846	CbGpPWpGaD
Lisinopril—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000226	0.0075	CbGpPWpGaD
Lisinopril—Enalapril—ACE—psoriasis	0.000226	0.0759	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—ACE—psoriasis	0.000173	0.00576	CbGpPWpGaD
Lisinopril—Nateglinide—PPARG—psoriasis	0.000168	0.0564	CrCbGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000134	0.00445	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—CP—psoriasis	0.000132	0.00439	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00013	0.00431	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—REN—psoriasis	0.000124	0.00412	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—LEP—psoriasis	0.000108	0.00357	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000103	0.00343	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL13—psoriasis	0.000103	0.00341	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL17A—psoriasis	9.45e-05	0.00314	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.04e-05	0.003	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL12B—psoriasis	8.79e-05	0.00292	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—HLA-E—psoriasis	8.58e-05	0.00285	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CXCL8—psoriasis	7.15e-05	0.00238	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.1e-05	0.00236	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—CP—psoriasis	6.72e-05	0.00223	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL10—psoriasis	6.43e-05	0.00213	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—CARM1—psoriasis	6.41e-05	0.00213	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL4—psoriasis	6.25e-05	0.00208	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.11e-05	0.00203	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.1e-05	0.00203	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.69e-05	0.00189	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.66e-05	0.00188	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.17e-05	0.00172	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—LEP—psoriasis	4.81e-05	0.0016	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IFNG—psoriasis	3.78e-05	0.00126	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.77e-05	0.00125	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.51e-05	0.00117	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.29e-05	0.00109	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CXCL8—psoriasis	3.19e-05	0.00106	CbGpPWpGaD
Lisinopril—Urticaria—Cyclosporine—psoriasis	3.14e-05	0.0003	CcSEcCtD
Lisinopril—Myalgia—Betamethasone—psoriasis	3.13e-05	0.000299	CcSEcCtD
Lisinopril—Myalgia—Dexamethasone—psoriasis	3.13e-05	0.000299	CcSEcCtD
Lisinopril—Body temperature increased—Cyclosporine—psoriasis	3.13e-05	0.000298	CcSEcCtD
Lisinopril—Abdominal pain—Cyclosporine—psoriasis	3.13e-05	0.000298	CcSEcCtD
Lisinopril—Anxiety—Betamethasone—psoriasis	3.12e-05	0.000298	CcSEcCtD
Lisinopril—Anxiety—Dexamethasone—psoriasis	3.12e-05	0.000298	CcSEcCtD
Lisinopril—Vomiting—Mycophenolic acid—psoriasis	3.11e-05	0.000296	CcSEcCtD
Lisinopril—Discomfort—Dexamethasone—psoriasis	3.1e-05	0.000295	CcSEcCtD
Lisinopril—Discomfort—Betamethasone—psoriasis	3.1e-05	0.000295	CcSEcCtD
Lisinopril—Dyspepsia—Hydrocortisone—psoriasis	3.09e-05	0.000295	CcSEcCtD
Lisinopril—Rash—Mycophenolic acid—psoriasis	3.08e-05	0.000294	CcSEcCtD
Lisinopril—Dermatitis—Mycophenolic acid—psoriasis	3.08e-05	0.000294	CcSEcCtD
Lisinopril—Pain—Prednisolone—psoriasis	3.08e-05	0.000293	CcSEcCtD
Lisinopril—Hepatitis—Methotrexate—psoriasis	3.08e-05	0.000293	CcSEcCtD
Lisinopril—Urticaria—Mycophenolate mofetil—psoriasis	3.07e-05	0.000292	CcSEcCtD
Lisinopril—Headache—Mycophenolic acid—psoriasis	3.06e-05	0.000292	CcSEcCtD
Lisinopril—Decreased appetite—Hydrocortisone—psoriasis	3.06e-05	0.000291	CcSEcCtD
Lisinopril—Pharyngitis—Methotrexate—psoriasis	3.05e-05	0.000291	CcSEcCtD
Lisinopril—Body temperature increased—Mycophenolate mofetil—psoriasis	3.05e-05	0.000291	CcSEcCtD
Lisinopril—Abdominal pain—Mycophenolate mofetil—psoriasis	3.05e-05	0.000291	CcSEcCtD
Lisinopril—Urinary tract disorder—Methotrexate—psoriasis	3.04e-05	0.00029	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Hydrocortisone—psoriasis	3.03e-05	0.000289	CcSEcCtD
Lisinopril—Fatigue—Hydrocortisone—psoriasis	3.03e-05	0.000289	CcSEcCtD
Lisinopril—Vision blurred—Prednisone—psoriasis	3.02e-05	0.000288	CcSEcCtD
Lisinopril—Urethral disorder—Methotrexate—psoriasis	3.02e-05	0.000288	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Triamcinolone—psoriasis	3.02e-05	0.000288	CcSEcCtD
Lisinopril—Pain—Hydrocortisone—psoriasis	3.01e-05	0.000287	CcSEcCtD
Lisinopril—Anaphylactic shock—Betamethasone—psoriasis	3e-05	0.000286	CcSEcCtD
Lisinopril—Anaphylactic shock—Dexamethasone—psoriasis	3e-05	0.000286	CcSEcCtD
Lisinopril—Oedema—Dexamethasone—psoriasis	3e-05	0.000286	CcSEcCtD
Lisinopril—Oedema—Betamethasone—psoriasis	3e-05	0.000286	CcSEcCtD
Lisinopril—Insomnia—Triamcinolone—psoriasis	2.99e-05	0.000285	CcSEcCtD
Lisinopril—Infection—Dexamethasone—psoriasis	2.98e-05	0.000284	CcSEcCtD
Lisinopril—Infection—Betamethasone—psoriasis	2.98e-05	0.000284	CcSEcCtD
Lisinopril—Ill-defined disorder—Prednisone—psoriasis	2.97e-05	0.000283	CcSEcCtD
Lisinopril—Paraesthesia—Triamcinolone—psoriasis	2.97e-05	0.000283	CcSEcCtD
Lisinopril—Feeling abnormal—Prednisolone—psoriasis	2.97e-05	0.000283	CcSEcCtD
Lisinopril—Anaemia—Prednisone—psoriasis	2.96e-05	0.000282	CcSEcCtD
Lisinopril—Shock—Betamethasone—psoriasis	2.95e-05	0.000282	CcSEcCtD
Lisinopril—Shock—Dexamethasone—psoriasis	2.95e-05	0.000282	CcSEcCtD
Lisinopril—Dyspnoea—Triamcinolone—psoriasis	2.95e-05	0.000281	CcSEcCtD
Lisinopril—Thrombocytopenia—Betamethasone—psoriasis	2.94e-05	0.00028	CcSEcCtD
Lisinopril—Thrombocytopenia—Dexamethasone—psoriasis	2.94e-05	0.00028	CcSEcCtD
Lisinopril—Tachycardia—Betamethasone—psoriasis	2.93e-05	0.000279	CcSEcCtD
Lisinopril—Tachycardia—Dexamethasone—psoriasis	2.93e-05	0.000279	CcSEcCtD
Lisinopril—Angioedema—Prednisone—psoriasis	2.93e-05	0.000279	CcSEcCtD
Lisinopril—Hypersensitivity—Cyclosporine—psoriasis	2.91e-05	0.000278	CcSEcCtD
Lisinopril—Dyspepsia—Triamcinolone—psoriasis	2.91e-05	0.000278	CcSEcCtD
Lisinopril—Erythema multiforme—Methotrexate—psoriasis	2.91e-05	0.000277	CcSEcCtD
Lisinopril—Nausea—Mycophenolic acid—psoriasis	2.9e-05	0.000277	CcSEcCtD
Lisinopril—Hyperhidrosis—Betamethasone—psoriasis	2.9e-05	0.000277	CcSEcCtD
Lisinopril—Hyperhidrosis—Dexamethasone—psoriasis	2.9e-05	0.000277	CcSEcCtD
Lisinopril—Feeling abnormal—Hydrocortisone—psoriasis	2.9e-05	0.000276	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.89e-05	0.000961	CbGpPWpGaD
Lisinopril—Malaise—Prednisone—psoriasis	2.89e-05	0.000276	CcSEcCtD
Lisinopril—Vertigo—Prednisone—psoriasis	2.88e-05	0.000274	CcSEcCtD
Lisinopril—Gastrointestinal pain—Hydrocortisone—psoriasis	2.87e-05	0.000274	CcSEcCtD
Lisinopril—Syncope—Prednisone—psoriasis	2.87e-05	0.000274	CcSEcCtD
Lisinopril—Tinnitus—Methotrexate—psoriasis	2.87e-05	0.000273	CcSEcCtD
Lisinopril—Anorexia—Dexamethasone—psoriasis	2.86e-05	0.000273	CcSEcCtD
Lisinopril—Anorexia—Betamethasone—psoriasis	2.86e-05	0.000273	CcSEcCtD
Lisinopril—Urticaria—Prednisolone—psoriasis	2.86e-05	0.000273	CcSEcCtD
Lisinopril—Fatigue—Triamcinolone—psoriasis	2.85e-05	0.000272	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.85e-05	0.000948	CbGpPWpGaD
Lisinopril—Hypersensitivity—Mycophenolate mofetil—psoriasis	2.84e-05	0.000271	CcSEcCtD
Lisinopril—Asthenia—Cyclosporine—psoriasis	2.84e-05	0.000271	CcSEcCtD
Lisinopril—Pain—Triamcinolone—psoriasis	2.83e-05	0.00027	CcSEcCtD
Lisinopril—Loss of consciousness—Prednisone—psoriasis	2.82e-05	0.000269	CcSEcCtD
Lisinopril—Hypotension—Betamethasone—psoriasis	2.81e-05	0.000268	CcSEcCtD
Lisinopril—Hypotension—Dexamethasone—psoriasis	2.81e-05	0.000268	CcSEcCtD
Lisinopril—Pruritus—Cyclosporine—psoriasis	2.8e-05	0.000267	CcSEcCtD
Lisinopril—Urticaria—Hydrocortisone—psoriasis	2.79e-05	0.000266	CcSEcCtD
Lisinopril—Angiopathy—Methotrexate—psoriasis	2.79e-05	0.000266	CcSEcCtD
Lisinopril—Abdominal pain—Hydrocortisone—psoriasis	2.78e-05	0.000265	CcSEcCtD
Lisinopril—Body temperature increased—Hydrocortisone—psoriasis	2.78e-05	0.000265	CcSEcCtD
Lisinopril—Mediastinal disorder—Methotrexate—psoriasis	2.77e-05	0.000264	CcSEcCtD
Lisinopril—Asthenia—Mycophenolate mofetil—psoriasis	2.77e-05	0.000264	CcSEcCtD
Lisinopril—Chills—Methotrexate—psoriasis	2.76e-05	0.000263	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Dexamethasone—psoriasis	2.74e-05	0.000261	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Betamethasone—psoriasis	2.74e-05	0.000261	CcSEcCtD
Lisinopril—Pruritus—Mycophenolate mofetil—psoriasis	2.73e-05	0.00026	CcSEcCtD
Lisinopril—Arthralgia—Prednisone—psoriasis	2.73e-05	0.00026	CcSEcCtD
Lisinopril—Myalgia—Prednisone—psoriasis	2.73e-05	0.00026	CcSEcCtD
Lisinopril—Feeling abnormal—Triamcinolone—psoriasis	2.73e-05	0.00026	CcSEcCtD
Lisinopril—Anxiety—Prednisone—psoriasis	2.72e-05	0.000259	CcSEcCtD
Lisinopril—Alopecia—Methotrexate—psoriasis	2.72e-05	0.000259	CcSEcCtD
Lisinopril—Insomnia—Betamethasone—psoriasis	2.72e-05	0.000259	CcSEcCtD
Lisinopril—Insomnia—Dexamethasone—psoriasis	2.72e-05	0.000259	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	2.71e-05	0.000258	CcSEcCtD
Lisinopril—Diarrhoea—Cyclosporine—psoriasis	2.71e-05	0.000258	CcSEcCtD
Lisinopril—Paraesthesia—Betamethasone—psoriasis	2.7e-05	0.000257	CcSEcCtD
Lisinopril—Paraesthesia—Dexamethasone—psoriasis	2.7e-05	0.000257	CcSEcCtD
Lisinopril—Discomfort—Prednisone—psoriasis	2.7e-05	0.000257	CcSEcCtD
Lisinopril—Mental disorder—Methotrexate—psoriasis	2.7e-05	0.000257	CcSEcCtD
Lisinopril—Erythema—Methotrexate—psoriasis	2.68e-05	0.000255	CcSEcCtD
Lisinopril—Malnutrition—Methotrexate—psoriasis	2.68e-05	0.000255	CcSEcCtD
Lisinopril—Hypersensitivity—Prednisolone—psoriasis	2.65e-05	0.000253	CcSEcCtD
Lisinopril—Dyspepsia—Dexamethasone—psoriasis	2.64e-05	0.000252	CcSEcCtD
Lisinopril—Dyspepsia—Betamethasone—psoriasis	2.64e-05	0.000252	CcSEcCtD
Lisinopril—Diarrhoea—Mycophenolate mofetil—psoriasis	2.64e-05	0.000252	CcSEcCtD
Lisinopril—Urticaria—Triamcinolone—psoriasis	2.63e-05	0.000251	CcSEcCtD
Lisinopril—Dysgeusia—Methotrexate—psoriasis	2.62e-05	0.00025	CcSEcCtD
Lisinopril—Body temperature increased—Triamcinolone—psoriasis	2.62e-05	0.000249	CcSEcCtD
Lisinopril—Dizziness—Cyclosporine—psoriasis	2.62e-05	0.000249	CcSEcCtD
Lisinopril—Oedema—Prednisone—psoriasis	2.62e-05	0.000249	CcSEcCtD
Lisinopril—Anaphylactic shock—Prednisone—psoriasis	2.62e-05	0.000249	CcSEcCtD
Lisinopril—Decreased appetite—Betamethasone—psoriasis	2.61e-05	0.000249	CcSEcCtD
Lisinopril—Decreased appetite—Dexamethasone—psoriasis	2.61e-05	0.000249	CcSEcCtD
Lisinopril—Infection—Prednisone—psoriasis	2.6e-05	0.000248	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Dexamethasone—psoriasis	2.59e-05	0.000247	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Betamethasone—psoriasis	2.59e-05	0.000247	CcSEcCtD
Lisinopril—Back pain—Methotrexate—psoriasis	2.59e-05	0.000247	CcSEcCtD
Lisinopril—Hypersensitivity—Hydrocortisone—psoriasis	2.59e-05	0.000247	CcSEcCtD
Lisinopril—Fatigue—Dexamethasone—psoriasis	2.59e-05	0.000247	CcSEcCtD
Lisinopril—Fatigue—Betamethasone—psoriasis	2.59e-05	0.000247	CcSEcCtD
Lisinopril—Shock—Prednisone—psoriasis	2.57e-05	0.000245	CcSEcCtD
Lisinopril—Pain—Dexamethasone—psoriasis	2.57e-05	0.000245	CcSEcCtD
Lisinopril—Pain—Betamethasone—psoriasis	2.57e-05	0.000245	CcSEcCtD
Lisinopril—Tachycardia—Prednisone—psoriasis	2.55e-05	0.000243	CcSEcCtD
Lisinopril—Dizziness—Mycophenolate mofetil—psoriasis	2.55e-05	0.000243	CcSEcCtD
Lisinopril—Skin disorder—Prednisone—psoriasis	2.54e-05	0.000242	CcSEcCtD
Lisinopril—Hyperhidrosis—Prednisone—psoriasis	2.53e-05	0.000241	CcSEcCtD
Lisinopril—Vision blurred—Methotrexate—psoriasis	2.52e-05	0.000241	CcSEcCtD
Lisinopril—Asthenia—Hydrocortisone—psoriasis	2.52e-05	0.00024	CcSEcCtD
Lisinopril—Vomiting—Cyclosporine—psoriasis	2.51e-05	0.00024	CcSEcCtD
Lisinopril—Rash—Cyclosporine—psoriasis	2.49e-05	0.000238	CcSEcCtD
Lisinopril—Anorexia—Prednisone—psoriasis	2.49e-05	0.000238	CcSEcCtD
Lisinopril—Dermatitis—Cyclosporine—psoriasis	2.49e-05	0.000238	CcSEcCtD
Lisinopril—Pruritus—Hydrocortisone—psoriasis	2.49e-05	0.000237	CcSEcCtD
Lisinopril—Ill-defined disorder—Methotrexate—psoriasis	2.48e-05	0.000237	CcSEcCtD
Lisinopril—Headache—Cyclosporine—psoriasis	2.48e-05	0.000236	CcSEcCtD
Lisinopril—Anaemia—Methotrexate—psoriasis	2.48e-05	0.000236	CcSEcCtD
Lisinopril—Feeling abnormal—Betamethasone—psoriasis	2.47e-05	0.000236	CcSEcCtD
Lisinopril—Feeling abnormal—Dexamethasone—psoriasis	2.47e-05	0.000236	CcSEcCtD
Lisinopril—Gastrointestinal pain—Betamethasone—psoriasis	2.46e-05	0.000234	CcSEcCtD
Lisinopril—Gastrointestinal pain—Dexamethasone—psoriasis	2.46e-05	0.000234	CcSEcCtD
Lisinopril—Vomiting—Mycophenolate mofetil—psoriasis	2.45e-05	0.000234	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—TNF—psoriasis	2.45e-05	0.000812	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NDUFA5—psoriasis	2.44e-05	0.000812	CbGpPWpGaD
Lisinopril—Hypersensitivity—Triamcinolone—psoriasis	2.44e-05	0.000232	CcSEcCtD
Lisinopril—Rash—Mycophenolate mofetil—psoriasis	2.43e-05	0.000232	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.43e-05	0.000808	CbGpPWpGaD
Lisinopril—Dermatitis—Mycophenolate mofetil—psoriasis	2.43e-05	0.000232	CcSEcCtD
Lisinopril—Headache—Mycophenolate mofetil—psoriasis	2.42e-05	0.00023	CcSEcCtD
Lisinopril—Malaise—Methotrexate—psoriasis	2.42e-05	0.00023	CcSEcCtD
Lisinopril—Vertigo—Methotrexate—psoriasis	2.41e-05	0.000229	CcSEcCtD
Lisinopril—Diarrhoea—Hydrocortisone—psoriasis	2.41e-05	0.000229	CcSEcCtD
Lisinopril—Leukopenia—Methotrexate—psoriasis	2.4e-05	0.000229	CcSEcCtD
Lisinopril—Urticaria—Dexamethasone—psoriasis	2.39e-05	0.000227	CcSEcCtD
Lisinopril—Urticaria—Betamethasone—psoriasis	2.39e-05	0.000227	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Prednisone—psoriasis	2.38e-05	0.000227	CcSEcCtD
Lisinopril—Dizziness—Prednisolone—psoriasis	2.38e-05	0.000227	CcSEcCtD
Lisinopril—Asthenia—Triamcinolone—psoriasis	2.37e-05	0.000226	CcSEcCtD
Lisinopril—Abdominal pain—Dexamethasone—psoriasis	2.37e-05	0.000226	CcSEcCtD
Lisinopril—Body temperature increased—Dexamethasone—psoriasis	2.37e-05	0.000226	CcSEcCtD
Lisinopril—Abdominal pain—Betamethasone—psoriasis	2.37e-05	0.000226	CcSEcCtD
Lisinopril—Body temperature increased—Betamethasone—psoriasis	2.37e-05	0.000226	CcSEcCtD
Lisinopril—Insomnia—Prednisone—psoriasis	2.37e-05	0.000226	CcSEcCtD
Lisinopril—Nausea—Cyclosporine—psoriasis	2.35e-05	0.000224	CcSEcCtD
Lisinopril—Paraesthesia—Prednisone—psoriasis	2.35e-05	0.000224	CcSEcCtD
Lisinopril—Pruritus—Triamcinolone—psoriasis	2.34e-05	0.000223	CcSEcCtD
Lisinopril—Cough—Methotrexate—psoriasis	2.34e-05	0.000223	CcSEcCtD
Lisinopril—Dizziness—Hydrocortisone—psoriasis	2.32e-05	0.000222	CcSEcCtD
Lisinopril—Dyspepsia—Prednisone—psoriasis	2.3e-05	0.000219	CcSEcCtD
Lisinopril—Nausea—Mycophenolate mofetil—psoriasis	2.29e-05	0.000219	CcSEcCtD
Lisinopril—Chest pain—Methotrexate—psoriasis	2.28e-05	0.000217	CcSEcCtD
Lisinopril—Arthralgia—Methotrexate—psoriasis	2.28e-05	0.000217	CcSEcCtD
Lisinopril—Myalgia—Methotrexate—psoriasis	2.28e-05	0.000217	CcSEcCtD
Lisinopril—Decreased appetite—Prednisone—psoriasis	2.27e-05	0.000217	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.27e-05	0.000755	CbGpPWpGaD
Lisinopril—Rash—Prednisolone—psoriasis	2.27e-05	0.000216	CcSEcCtD
Lisinopril—Dermatitis—Prednisolone—psoriasis	2.27e-05	0.000216	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	2.26e-05	0.000216	CcSEcCtD
Lisinopril—Fatigue—Prednisone—psoriasis	2.25e-05	0.000215	CcSEcCtD
Lisinopril—Headache—Prednisolone—psoriasis	2.25e-05	0.000215	CcSEcCtD
Lisinopril—Discomfort—Methotrexate—psoriasis	2.25e-05	0.000215	CcSEcCtD
Lisinopril—Constipation—Prednisone—psoriasis	2.24e-05	0.000213	CcSEcCtD
Lisinopril—Vomiting—Hydrocortisone—psoriasis	2.23e-05	0.000213	CcSEcCtD
Lisinopril—Rash—Hydrocortisone—psoriasis	2.22e-05	0.000211	CcSEcCtD
Lisinopril—Dermatitis—Hydrocortisone—psoriasis	2.21e-05	0.000211	CcSEcCtD
Lisinopril—Confusional state—Methotrexate—psoriasis	2.2e-05	0.00021	CcSEcCtD
Lisinopril—Headache—Hydrocortisone—psoriasis	2.2e-05	0.00021	CcSEcCtD
Lisinopril—Dizziness—Triamcinolone—psoriasis	2.19e-05	0.000209	CcSEcCtD
Lisinopril—Anaphylactic shock—Methotrexate—psoriasis	2.19e-05	0.000208	CcSEcCtD
Lisinopril—Infection—Methotrexate—psoriasis	2.17e-05	0.000207	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.17e-05	0.00072	CbGpPWpGaD
Lisinopril—Feeling abnormal—Prednisone—psoriasis	2.16e-05	0.000205	CcSEcCtD
Lisinopril—Asthenia—Dexamethasone—psoriasis	2.15e-05	0.000205	CcSEcCtD
Lisinopril—Asthenia—Betamethasone—psoriasis	2.15e-05	0.000205	CcSEcCtD
Lisinopril—Thrombocytopenia—Methotrexate—psoriasis	2.14e-05	0.000204	CcSEcCtD
Lisinopril—Gastrointestinal pain—Prednisone—psoriasis	2.14e-05	0.000204	CcSEcCtD
Lisinopril—Nausea—Prednisolone—psoriasis	2.14e-05	0.000204	CcSEcCtD
Lisinopril—Pruritus—Dexamethasone—psoriasis	2.12e-05	0.000203	CcSEcCtD
Lisinopril—Pruritus—Betamethasone—psoriasis	2.12e-05	0.000203	CcSEcCtD
Lisinopril—Skin disorder—Methotrexate—psoriasis	2.12e-05	0.000202	CcSEcCtD
Lisinopril—Hyperhidrosis—Methotrexate—psoriasis	2.11e-05	0.000201	CcSEcCtD
Lisinopril—Vomiting—Triamcinolone—psoriasis	2.1e-05	0.000201	CcSEcCtD
Lisinopril—Nausea—Hydrocortisone—psoriasis	2.09e-05	0.000199	CcSEcCtD
Lisinopril—Rash—Triamcinolone—psoriasis	2.09e-05	0.000199	CcSEcCtD
Lisinopril—Dermatitis—Triamcinolone—psoriasis	2.08e-05	0.000199	CcSEcCtD
Lisinopril—Anorexia—Methotrexate—psoriasis	2.08e-05	0.000199	CcSEcCtD
Lisinopril—ABCB1—Metabolism—CYP2S1—psoriasis	2.08e-05	0.00069	CbGpPWpGaD
Lisinopril—Urticaria—Prednisone—psoriasis	2.08e-05	0.000198	CcSEcCtD
Lisinopril—Headache—Triamcinolone—psoriasis	2.07e-05	0.000198	CcSEcCtD
Lisinopril—Body temperature increased—Prednisone—psoriasis	2.07e-05	0.000197	CcSEcCtD
Lisinopril—Abdominal pain—Prednisone—psoriasis	2.07e-05	0.000197	CcSEcCtD
Lisinopril—Diarrhoea—Betamethasone—psoriasis	2.05e-05	0.000196	CcSEcCtD
Lisinopril—Diarrhoea—Dexamethasone—psoriasis	2.05e-05	0.000196	CcSEcCtD
Lisinopril—Hypotension—Methotrexate—psoriasis	2.04e-05	0.000195	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Methotrexate—psoriasis	1.99e-05	0.00019	CcSEcCtD
Lisinopril—Dizziness—Betamethasone—psoriasis	1.99e-05	0.000189	CcSEcCtD
Lisinopril—Dizziness—Dexamethasone—psoriasis	1.99e-05	0.000189	CcSEcCtD
Lisinopril—Insomnia—Methotrexate—psoriasis	1.98e-05	0.000188	CcSEcCtD
Lisinopril—Nausea—Triamcinolone—psoriasis	1.97e-05	0.000187	CcSEcCtD
Lisinopril—Paraesthesia—Methotrexate—psoriasis	1.96e-05	0.000187	CcSEcCtD
Lisinopril—Dyspnoea—Methotrexate—psoriasis	1.95e-05	0.000186	CcSEcCtD
Lisinopril—Somnolence—Methotrexate—psoriasis	1.94e-05	0.000185	CcSEcCtD
Lisinopril—Hypersensitivity—Prednisone—psoriasis	1.93e-05	0.000184	CcSEcCtD
Lisinopril—Dyspepsia—Methotrexate—psoriasis	1.92e-05	0.000183	CcSEcCtD
Lisinopril—Vomiting—Betamethasone—psoriasis	1.91e-05	0.000182	CcSEcCtD
Lisinopril—Vomiting—Dexamethasone—psoriasis	1.91e-05	0.000182	CcSEcCtD
Lisinopril—Decreased appetite—Methotrexate—psoriasis	1.9e-05	0.000181	CcSEcCtD
Lisinopril—Rash—Dexamethasone—psoriasis	1.89e-05	0.000181	CcSEcCtD
Lisinopril—Rash—Betamethasone—psoriasis	1.89e-05	0.000181	CcSEcCtD
Lisinopril—Dermatitis—Betamethasone—psoriasis	1.89e-05	0.00018	CcSEcCtD
Lisinopril—Dermatitis—Dexamethasone—psoriasis	1.89e-05	0.00018	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Methotrexate—psoriasis	1.89e-05	0.00018	CcSEcCtD
Lisinopril—Fatigue—Methotrexate—psoriasis	1.88e-05	0.00018	CcSEcCtD
Lisinopril—Headache—Betamethasone—psoriasis	1.88e-05	0.000179	CcSEcCtD
Lisinopril—Headache—Dexamethasone—psoriasis	1.88e-05	0.000179	CcSEcCtD
Lisinopril—Asthenia—Prednisone—psoriasis	1.88e-05	0.000179	CcSEcCtD
Lisinopril—Pain—Methotrexate—psoriasis	1.87e-05	0.000178	CcSEcCtD
Lisinopril—Pruritus—Prednisone—psoriasis	1.85e-05	0.000176	CcSEcCtD
Lisinopril—Feeling abnormal—Methotrexate—psoriasis	1.8e-05	0.000172	CcSEcCtD
Lisinopril—Diarrhoea—Prednisone—psoriasis	1.79e-05	0.000171	CcSEcCtD
Lisinopril—Gastrointestinal pain—Methotrexate—psoriasis	1.79e-05	0.00017	CcSEcCtD
Lisinopril—Nausea—Betamethasone—psoriasis	1.78e-05	0.00017	CcSEcCtD
Lisinopril—Nausea—Dexamethasone—psoriasis	1.78e-05	0.00017	CcSEcCtD
Lisinopril—Urticaria—Methotrexate—psoriasis	1.74e-05	0.000166	CcSEcCtD
Lisinopril—Dizziness—Prednisone—psoriasis	1.73e-05	0.000165	CcSEcCtD
Lisinopril—Body temperature increased—Methotrexate—psoriasis	1.73e-05	0.000165	CcSEcCtD
Lisinopril—Abdominal pain—Methotrexate—psoriasis	1.73e-05	0.000165	CcSEcCtD
Lisinopril—Vomiting—Prednisone—psoriasis	1.66e-05	0.000159	CcSEcCtD
Lisinopril—Rash—Prednisone—psoriasis	1.65e-05	0.000157	CcSEcCtD
Lisinopril—Dermatitis—Prednisone—psoriasis	1.65e-05	0.000157	CcSEcCtD
Lisinopril—Headache—Prednisone—psoriasis	1.64e-05	0.000156	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.61e-05	0.000535	CbGpPWpGaD
Lisinopril—Hypersensitivity—Methotrexate—psoriasis	1.61e-05	0.000154	CcSEcCtD
Lisinopril—Asthenia—Methotrexate—psoriasis	1.57e-05	0.00015	CcSEcCtD
Lisinopril—Nausea—Prednisone—psoriasis	1.55e-05	0.000148	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.55e-05	0.000515	CbGpPWpGaD
Lisinopril—Pruritus—Methotrexate—psoriasis	1.55e-05	0.000147	CcSEcCtD
Lisinopril—Diarrhoea—Methotrexate—psoriasis	1.5e-05	0.000143	CcSEcCtD
Lisinopril—Dizziness—Methotrexate—psoriasis	1.45e-05	0.000138	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.41e-05	0.000468	CbGpPWpGaD
Lisinopril—Vomiting—Methotrexate—psoriasis	1.39e-05	0.000132	CcSEcCtD
Lisinopril—Rash—Methotrexate—psoriasis	1.38e-05	0.000131	CcSEcCtD
Lisinopril—Dermatitis—Methotrexate—psoriasis	1.38e-05	0.000131	CcSEcCtD
Lisinopril—Headache—Methotrexate—psoriasis	1.37e-05	0.000131	CcSEcCtD
Lisinopril—Nausea—Methotrexate—psoriasis	1.3e-05	0.000124	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.21e-05	0.000401	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.06e-05	0.000353	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CARM1—psoriasis	1.02e-05	0.000337	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CAT—psoriasis	6.24e-06	0.000207	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOE—psoriasis	4.85e-06	0.000161	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARG—psoriasis	4.23e-06	0.00014	CbGpPWpGaD
